Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Inhibitor of phospholipase enzymes

A technology selected from, alkyl, applied in the field of chemical inhibitors, can solve the problem of unpurified protein

Inactive Publication Date: 2001-06-13
GENETICS INST INC
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the protein was not purified to homogeneity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 24

[0162] Each of the compounds in Examples 2-11 below was prepared by a first step as described in Example 1, Step 9, using the appropriate thiol, followed by a second step as described in Example 1, Step 10. Example 24-[(3-Chloro-5-[(cyclopentylcarbonyl)amino]-2-{[(2-furylmethyl)sulfanyl]methyl}-1H-indol-1-yl ) Methyl] benzoic acid Example 34-[(3-chloro-5-[(cyclopentylcarbonyl)amino]-2-{[(4-hydroxyl-6-phenyl-2-pyrimidinyl)sulfanyl ]methyl}-1H-indol-1-yl)methyl]benzoic acid embodiment 4

[0163] 4-{[3-Chloro-5-[(cyclopentylcarbonyl)amino]-2-({[4-(2-thienyl)-2-pyrimidinyl]sulfanyl}methyl)-1H-ind Indol-1-yl]methyl}benzoic acid Example 54-({3-Chloro-5-[(cyclopentylcarbonyl)amino]-2-[(2,4-dibromophenoxy)methyl] -1H-indol-1-yl}methyl)benzoic acid Example 64-({3-chloro-5-[(cyclopentylcarbonyl)amino]-2-[(cyclopentylsulfanyl)methyl ]-1H-indol-1-yl}methyl)benzoic acid Example 74-({3-chloro-5-[(cyclopentylcarbonyl)amino]-2-[(propylsulfanyl)methyl ]-1H-indol-1-yl}methyl)benzoic acid Ex...

Embodiment 12

[0166]Step 2 - The title compound was prepared from the intermediate of Step 1 following the procedure described in Example 1, Steps 8-10, using the appropriate thiol. Example 124-({5-[(3-carboxypropionyl)amino]-3-chloro-2-[(phenethylsulfanyl)methyl]-1H-indol-1-yl}methyl) Benzoic acid example 134-[(5-[(3-carboxypropionyl)amino]-3-chloro-2-{[(3-methylbenzyl)sulfanyl]methyl}-1H-indole- 1-yl)methyl]benzoic acid Example 14 4-({2-({[4-(tert-butyl)benzyl]sulfanyl}methyl)-5-[(3-carboxypropionyl)amino] -3-Chloro-1H-indol-1-yl}methyl)benzoic acid Example 15 4-({3-Chloro-5-(3-furanoylamino)-2-[(2-naphthylsulfanyl )methyl]-1H-indol-1-yl}methyl)benzoic acid

[0167] The title compound was prepared as described in Example 43 using the appropriate acylating reagent.

[0168] The following Examples 17-21 were prepared as described in Example 43 using the appropriate acylating reagent. Example 17 4-({3-chloro-5-{[3-(diethylamino)propionyl]amino}-2-[(2-naphthylsulfanyl)methyl]-1H-indole-1 ...

Embodiment 2

[0168] The following Examples 17-21 were prepared as described in Example 43 using the appropriate acylating reagent. Example 17 4-({3-chloro-5-{[3-(diethylamino)propionyl]amino}-2-[(2-naphthylsulfanyl)methyl]-1H-indole-1 - Base} methyl) benzoic acid example 18 4-({3-chloro-2-[(2-naphthylsulfanyl)methyl]-5-[(3-thienylcarbonyl)amino]-1H-ind Indol-1-yl}methyl)benzoic acid Example 19 4-({5-{[(benzylamino)carbonyl]amino}-3-chloro-2-[(2-naphthylsulfanyl)methyl] -1H-indol-1-yl}methyl)benzoic acid Example 204-({5-{[(butylamino)carbonyl]amino}-3-chloro-2-[(2-naphthylsulfanyl )methyl]-1H-indol-1-yl}methyl)benzoic acid Example 213-[({1-(4-carboxybenzyl)-3-chloro-2-[(2-naphthylsulfane Base)methyl]-1H-indol-5-yl}amino)carbonyl]benzoic acid Example 224-{[5-(benzyloxy)-2-[(E)-2-carboxyvinyl]-3 -(2-Naphthoyl)-1H-indol-1-yl]methyl}benzoic acid Step 1

[0169] Cool the solution of 2(tert-butyldimethylsilyloxymethyl)-5-benzyloxyindole (2.0g, 5.4mmol) in anhydrous ether (10ml) to -78°C, add ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Novel compounds are disclosed which inhibit the activity of phospholipase enzymes, particularly cytosolic phospholipase A2. Pharmaceutical compositions comprising such compounds and methods of treatment using such compositions are also disclosed.

Description

Background of the invention [0001] The present invention relates to chemical inhibitors of the activity of various phospholipases, especially phospholipase A2. [0002] Leukotrienes and prostaglandins are important mediators of inflammation, each of which leads to inflammatory responses in different ways. Leukotrienes recruit inflammatory cells such as neutrophils to the site of inflammation, facilitate extravasation of these cells and stimulate the release of superoxides and proteases that damage the tissue. Leukotrienes also play a pathophysiological role in allergic reactions experienced in asthma [see B. Samuelson et al., Science, 237:1171-76 (1987)]. Prostaglandins aggravate inflammation by increasing blood flow and thus enhancing leukocyte infiltration to the inflamed site. Prostaglandins also exacerbate pain responses induced by stimuli. [0003] Prostaglandins and leukotrienes are unstable, are not stored in cells, but are synthesized from arachidonic acid in respon...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/40A61K31/403A61K31/404A61K31/4709A61K31/506A61K31/5377A61P29/00A61P43/00C07D209/10C07D209/12C07D209/14C07D209/18C07D209/30C07D209/42C07D401/12C07D403/04C07D403/06C07D403/12C07D405/12C07D409/12C07D409/14C07D413/04C07D417/10
CPCC07D401/12C07D209/30C07D209/12C07D403/12C07D405/12C07D409/14C07D209/42A61P29/00A61P43/00
Inventor J·S·赛拉N·凯拉J·C·麦库F·洛夫林J·E·贝米斯Y·B·向
Owner GENETICS INST INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com